← All organizations

Aerpio Therapeutics

For profit

Also known as: Aerpio Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 21, 2020

Acquired by Aadi, LLC on May 17, 2021

Timeline

2010s

Jun 1, 2011
Aerpio Therapeutics— Founded

2020s

May 17, 2021
Aadi, LLC— Acquired By

Drugs by trial phase (5 distinct, 9 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

akb-4924

Indications

Studied for

Recent trials (11)

NCT04511650Lead sponsorPhase 2Oct 21, 2020
NCT04405245Lead sponsorPhase 2Jun 30, 2020
NCT04284514Lead sponsorPhase 1May 2, 2019
NCT03197870Lead sponsorPhase 2Jun 1, 2017
NCT02914262Lead sponsorPhase 1Aug 1, 2016
NCT02858271Study chairPhase 1Jul 1, 2016
NCT02858271Lead sponsorPhase 1Jul 1, 2016
NCT02387788Lead sponsorPhase 2Jan 1, 2015
NCT02050828Lead sponsorPhase 2Jan 1, 2014
NCT01702441Study directorPhase 1/Phase 2Sep 1, 2012
NCT01702441Lead sponsorPhase 1/Phase 2Sep 1, 2012

Details

Founded: Cincinnati, OH, US Jun 1, 2011
Last known activity: Oct 21, 2020